Journal of the Royal Society of Medicine

Papers
(The H4-Index of Journal of the Royal Society of Medicine is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Symptoms, complications and management of long COVID: a review477
Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?217
Uncertainty and COVID-19: how are we to respond?166
The primary care response to COVID-19 in England's National Health Service100
COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors86
Environmental impact of personal protective equipment distributed for use by health and social care services in England in the first six months of the COVID-19 pandemic82
Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis80
Four months into the COVID-19 pandemic, Sweden’s prized herd immunity is nowhere in sight66
Loneliness, social isolation, cardiovascular disease and mortality: a synthesis of the literature and conceptual framework64
Ethnicity, household composition and COVID-19 mortality: a national linked data study64
Anger and confrontation during the COVID-19 pandemic: a national cross-sectional survey in the UK51
Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction45
COVID-19 presents opportunities and threats to transport and health42
Clinical impact of multi-parameter continuous non-invasive monitoring in hospital wards: a systematic review and meta-analysis39
Health inequalities: the hidden cost of COVID-19 in NHS hospital trusts?38
COVID-19: the great unequaliser36
Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications35
What do countries need to do to implement effective ‘find, test, trace, isolate and support’ systems?33
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study30
Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis30
Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps29
The costs of coronavirus vaccines and their pricing29
Protecting older people from COVID-19: should the United Kingdom start at age 60?23
0.092900037765503